Status: Recruiting
Investigating Ovulation Inhibition for Use as a Contraceptive
A single-centre, open-label, randomised, phase II study on the maintenance of ovulation inhibition after intentional application errors during 84 days of treatment with MR 130A 01 contraceptive transdermal patch
Participants needed: 60
Trial details
Phase: Phase 2Age: 18-35Biological sex: FemaleType: InterventionalSponsor: Mylan Pharmaceuticals IncUpdated: Jan 26, 2026Locations: 1
Eligibility criteria
1. Healthy, post-menarcheal and premenopausal women of age 18 to 35 years (inclu...
1. Known hypersensitivity or intolerance to any ingredient of the investigationa... [+2]